Stay updated with breaking news from First Half Year. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Net earnings were $810.4 million, or $0.79 per diluted share for the second quarter of fiscal 2023 compared with $694.8 million, or $0.65 per diluted share for...
Net earnings were $810.4 million, or $0.79 per diluted share for the second quarter of fiscal 2023 compared with $694.8 million, or $0.65 per diluted share for...
Presentation Operator MessageOperator Ladies and gentlemen, thank you for standing by, and welcome to Quhuo's First Half Year of 2022 Earnings Conference Call. [Operator Instructions] Today's... | November 15, 2022
EQS-News: Vivoryon Therapeutics N.V. / Key word(s): Half Year Results Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports H1 2022 Financial Results and Highlights Operational Progress
Investegate announcements from Accentro Real Estate AG, ACCENTRO With Revenue Boost in First Half Year